...
机译:NiLotinib Dereculates细胞周期检查点,ABC转运蛋白基因和JAK-STAT在慢性相慢性骨髓白血病(CP-CML)患者中的CD34 + / LIN细胞的途径在12个月后治疗后
ASST Grande Osped Metropolitano Niguarda Dept Hematol Milan Italy;
ASST Grande Osped Metropolitano Niguarda Dept Hematol Milan Italy;
ASST Spedali Civili Brescia Dept Hematol Brescia Italy;
ASST Spedali Civili Brescia Dept Hematol Brescia Italy;
ASST Grande Osped Metropolitano Niguarda Dept Hematol Milan Italy;
Univ Padua Dept Informat Engn Padua Italy;
Univ Padua Dept Informat Engn Padua Italy;
Desio Hosp Internal Med Hematol Desio Italy;
Valduce Hosp Dep Internal Med Como Italy;
Fdn IRCCS Policlin San Matteo Dept Hematol Oncol Pavia Italy;
San Gerardo Hosp Dept Hematol Monza Italy;
Fdn IRCCS Ca Granda Osped Maggiore Policlin Hematol Div Milan Italy;
Hematol &
Bone Marrow Transplantat Unit San Raffaele Sci Unit Milan Italy;
Fdn IRCCS Ist Tumori Div Hematol Milan Italy;
ASST Valle Olona Osped Circolo Busto Arsizio Italy;
ASST Cremona Cremona Italy;
ASST Valle Olona St Antonio Abate Gallarate Italy;
ASST Lecco Lecce Italy;
Sacco Hosp Hematol &
Transfus Med Milan Italy;
Fdn IRCCS Ca Granda Osped Maggiore Policlin Hematol Div Milan Italy;
ASST Grande Osped Metropolitano Niguarda Pathol Dept Cytogenet Milan Italy;
ASST Grande Osped Metropolitano Niguarda Lombardy Hematol Network Milan Italy;
ASST Grande Osped Metropolitano Niguarda Dept Hematol Milan Italy;
机译:NiLotinib Dereculates细胞周期检查点,ABC转运蛋白基因和JAK-STAT在慢性相慢性骨髓白血病(CP-CML)患者中的CD34 + / LIN细胞的途径在12个月后治疗后
机译:酪氨酸激酶抑制剂(TKI)在常规临床实践中,在前12个月内为前12个月内切换模式,慢性相慢性骨髓白血病(CP-CML)患者(CP-CML)患者(PTS)的观察研究
机译:CD34 +造血细胞中PI3K / AKT,WNT / B-Catenin,SHH,NOTCH和MAPK信号通路中基因的表达差异,从慢性骨髓白血病和健康对照中获得慢性相位患者
机译:来自Ph(+)慢性髓细胞性白血病患者的γδT细胞的培养,鉴定和细胞毒性活性:在细胞治疗中的潜在作用。
机译:尼洛替尼治疗12个月后慢性期慢性髓细胞性白血病患者CD34 + / lin-细胞中干扰细胞周期,ABC转运蛋白和JAK-STAT信号通路
机译:Nilotinib在慢性相位慢性骨髓白血病患者的CD34 + / Lin细胞中干扰细胞周期,ABC转运蛋白和JAK-STAT信号通路在12个月后治疗后